Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 14.09 INR
Change Today -0.68 / -4.60%
Volume 38.3K
AD On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:28 AM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

aarey drugs & pharmaceut (AD) Snapshot

Open
14.98
Previous Close
14.77
Day High
14.98
Day Low
13.76
52 Week High
10/14/14 - 22.70
52 Week Low
06/4/15 - 11.27
Market Cap
236.9M
Average Volume 10 Days
20.0K
EPS TTM
0.65
Shares Outstanding
16.8M
EX-Date
--
P/E TM
21.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for AAREY DRUGS & PHARMACEUT (AD)

Related News

No related news articles were found.

aarey drugs & pharmaceut (AD) Related Businessweek News

No Related Businessweek News Found

aarey drugs & pharmaceut (AD) Details

Aarey Drugs & Pharmaceuticals Limited manufactures and trades in API/bulk drugs primarily in India. The company’s API products include metronidazole and metronidazole benzoate; and pharma products comprise 2-methyl-5-nitroimidazole and 1-methylimidazole. It also imports and distributes various industrial chemicals and solvents, including methanol, toluene, xylene, acetic acid (glacial), acetone, liquor ammonia, and IPA. The company was formerly known as Niharika Textiles & Chemicals Private Limited and changed its name to Aarey Drugs & Pharmaceuticals Limited in March 1993. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai, India.

Founded in 1990

aarey drugs & pharmaceut (AD) Top Compensated Officers

Managing Director, Director, Member of Audit ...
Total Annual Compensation: 300.0K
Compensation as of Fiscal Year 2014.

aarey drugs & pharmaceut (AD) Key Developments

Aarey Drugs & Pharmaceuticals Ltd. Reports Audited Consolidated and Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2015

Aarey Drugs & Pharmaceuticals Ltd. reported audited consolidated and standalone earnings results for the fourth quarter and full year ended March 31, 2015. For the quarter, on consolidated basis, net income from sales/services was INR 771.902 million against INR 369.891 million last year. Operating loss before interest was INR 15.841 million against INR 9.425 million last year. Profit from ordinary activities before tax was INR 4.065 million against loss from ordinary activities before tax of INR 1.015 million last year. Net profit was INR 0.849 million or INR 0.05 per basic and diluted share before extraordinary items against net loss of INR 2.504 million or INR 0.15 per basic and diluted share before extraordinary items last year. For the year, on consolidated basis, net income from sales/services was INR 2,134.414 million against INR 1,997.250 million last year. Operating profit before interest was INR 0.496 million against INR 5.722 million last year. Profit from ordinary activities before tax was INR 14.100 million against INR 13.499 million last year. Net profit was INR 10.884 million or INR 0.65 per basic and diluted share before extraordinary items against INR 10.510 million or INR 0.63 per basic and diluted share before extraordinary items last year. For the quarter, on standalone basis, net income from sales/services was INR 617.522 million against INR 244.111 million last year. Operating loss before interest was INR 12.674 million against INR 8.141 million last year. Profit from ordinary activities before tax was INR 3.251 million against INR 0.424 million last year. Net profit was INR 0.678 million or INR 0.04 per basic and diluted share before extraordinary items against net loss of INR 1.001 million or INR 0.06 per basic and diluted share before extraordinary items last year. For the year, on standalone basis, net income from sales/services was INR 1,571.279 million against INR 1,318.910 million last year. Operating loss before interest was INR 0.661 million against operating profit before interest of INR 3.847 million last year. Profit from ordinary activities before tax was INR 11.125 million against INR 12.143 million last year. Net profit was INR 8.552 million or INR 0.51 per basic and diluted share before extraordinary items against INR 9.504 million or INR 0.56 per basic and diluted share before extraordinary items last year.

Aarey Drugs & Pharmaceuticals Ltd., Board Meeting, May 30, 2015

Aarey Drugs & Pharmaceuticals Ltd., Board Meeting, May 30, 2015. Agenda: To consider audited results.

Aarey Drugs & Pharmaceuticals Ltd. Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Aarey Drugs & Pharmaceuticals Ltd. announced unaudited earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported net income from operations of INR 527.662 million against INR 583.387 million for the same period a year ago. Operating profit before interest was INR 3.833 million against INR 3.730 million a year ago. Profit from ordinary activities before tax was INR 1.530 million against INR 2.514 million a year ago. Net profit for the period was INR 1.530 million or INR 0.09 per basic and diluted share against INR 2.514 million or INR 0.15 per basic and diluted share a year ago. For the nine months, the company reported net income from operations of INR 1,362.512 million against INR 1,627.359 million for the same period a year ago. Operating profit before interest was INR 16.337 million against INR 15.147 million a year ago. Profit from ordinary activities before tax was INR 10.035 million against INR 14.514 million a year ago. Net profit for the period was INR 10.035 million or INR 0.60 per basic and diluted share against INR 13.014 million or INR 0.78 per basic and diluted share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AD:IN 14.09 INR -0.68

AD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AD.
View Industry Companies
 

Industry Analysis

AD

Industry Average

Valuation AD Industry Range
Price/Earnings 22.0x
Price/Sales 0.1x
Price/Book -- Not Meaningful
Price/Cash Flow 11.2x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AAREY DRUGS & PHARMACEUT, please visit www.aareydrugs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.